CD4 and neoplasm: Our analysis of pretreatment peripheral blood T cell phenotype revealed the presence of a circulating population of CD4+ and CD8+ T cells that express CD103, a marker of tissue-resident tumor-infiltrating lymphocytes that are rarely found in peripheral blood and that are enriched for tumor-reactive T cells with a distinct T-cell receptor (TCR) repertoire30.